New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

Clinical trial NCT06345235 · UNKNOWN

Trial details

NCT number: NCT06345235
Sponsor: John Paul II Hospital, Krakow
Status: UNKNOWN
Study type: OBSERVATIONAL

Transthyretin Amyloidosis

Start date: 2023-07-11
Primary completion: 2024-07-11
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.